203
Views
0
CrossRef citations to date
0
Altmetric
Research

Patient medication counselling in community pharmacy: evaluation of the quality and content

ORCID Icon &
Article: 103 | Received 28 Jun 2022, Accepted 05 Dec 2022, Published online: 04 Dec 2023

References

  • George PP, Molina JAD, Cheah J, Chan SC, Lim BP. The evolving role of the community pharmacist in chronic disease management—a literature review. Ann Acad Med Singapore. 2010;39(11):861–867.
  • Goode JV, Owen J, Page A, Gatewood S. Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States. Pharm J Pharm Educ Pract. 2019;7(3):106. https://doi.org/10.3390/pharmacy7030106.
  • Joseph Moose P, Ashley Branham P. Pharmacists as influencers of patient adherence. Pharm Times Oncol Ed. 2014;1(5).
  • Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149–1155.
  • Daly CJ, Quinn B, Mak A, Jacobs DM. Community pharmacists’ perceptions of patient care services within an enhanced service network. Pharmacy. 2020;8(3):172.
  • Alfadl AA, Alrasheedy AA, Alhassun MS. Evaluation of medication counseling practice at community pharmacies in Qassim region, Saudi Arabia. Saudi Pharm J SPJ. 2018;26(2):258–262.
  • Perri M, Kotzan J, Pritchard L, Ozburn W, Francisco G. OBRA ’90: the impact on pharmacists and patients. Am Pharm. 1995;35(2):24–28.
  • Royal Pharmaceutical Society of Great Britain. 1996. http://www.rpsgb.org.uk.
  • Palaian S, Prabhu M, Shankar PR. Patient counseling by pharmacist—a focus on chronic illness. Pak J Pharm Sci. 2006;19:65–72.
  • Willeboordse F, Hugtenburg JG, Schellevis FG, Elders PJM. Patient participation in medication reviews is desirable but not evidence-based: a systematic literature review. Br J Clin Pharmacol. 2014;78(6):1201–1216.
  • Qudah B, Thakur T, Chewning B. Factors influencing patient participation in medication counseling at the community pharmacy: a systematic review. Res Soc Adm Pharm. 2021;17(11):1863–1876.
  • Yang S, Kim D, Choi HJ, Chang MJ. A comparison of patients’ and pharmacists’ satisfaction with medication counseling provided by community pharmacies: a cross-sectional survey. BMC Health Serv Res. 2016;16(1):131.
  • Chandra A, Malcolm N, Fetters M. Practicing health promotion through pharmacy counseling activities. Health Promot Pract. 2003;4(1):64–71.
  • Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44(1):22–29.
  • Ejeta F, Feyisa D, Kebede O, Aferu T, Siraj J, Feyissa D, et al. Medication counseling practices in medicine retail outlets found in Bench Sheko Zone, Southern Nations, Nationalities, and Peoples’ Region, South West Ethiopia. Pragmatic Obs Res. 2021;12:105–117.
  • Hussain S, Hussain AAS, Hussain K, Asif MA, Khalil MM, Rahman DA, et al. Pharmacist–patient counselling in Dubai: assessment and reflection on patient satisfaction. Eur J Hosp Pharm. 2013;20(4):241–247.
  • Coelho RB, Costa FA. Impact of pharmaceutical counseling in minor health problems in rural Portugal. Pharm Pract Granada. 2014;12(4):451.
  • American Society of Health-System Pharmacists. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997;54(4):431–434.
  • Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Soc Adm Pharm. 2009;5(3):197–210.
  • Kim C. Draft legislation on patent-regulatory approval linkage system. 2014. http://www.lexology.com/library/detail.aspx?g=cdf12ad9. Accessed 22 June 2022.
  • Ward PR, Bissell P, Noyce PR. Criteria for assessing the appropriateness of patient counseling in community pharmacies. Ann Pharmacother. 2000;34(2):170–175.
  • Erah PO. Editorial: The challenging roles of pharmacists in hospital and community pharmacy practice in Nigeria. Trop J Pharm Res. 2003;2(2):195–196.
  • Awaisu A, Mohammed S, Yakubu R. Chapter 17—Pharmacy practice in Nigeria. In: Fathelrahman AI, Ibrahim MIM, Wertheimer AI, editors. Pharmacy practice in developing countries. Boston: Academic Press; 2016. p. 343–370.
  • Pharmacists Council of Nigeria. Four part compendium of minimum standard of pharmacy practice in Nigeria. Abuja: Pharmacists Council of Nigeria; 2005.
  • National Universities Commission. Benchmark Minumum Academic Standards for Undergraduate Programmes in Nigerian Universities, Pharmacy. National Universities Commission, Nigeria. 2014. https://nuc.edu.ng/wp-content/uploads/2015/09/Pharmacy%20Draft%20BMAS.pdf. Accessed 14 Nov 2022.
  • Pharmacy Council of Nigeria. Mandatory continuing professional development (mcpd) programme for there-certification of pharmacists in Nigeria modules X, XI, XI. Pharmacy Council of Nigeria, Abuja, Nigeria; 2013. https://www.pcnmcpd.com/. Accessed 14 Nov 2022.
  • USP medication counselling behaviour guidelines. 1992. http://www.ipsf.org. Accessed 14 Nov 2022.
  • American Society of Consultant Pharmacists. Guidelines for pharmacist counseling of geriatric patients. 1998. https://www.ascp/com. Accessed 14 Nov 2022.
  • Puumalainen I, Halonen P, Enlund H, Johnson K, Airaksinen M. Validation of the United States Pharmacopeia (USP) medication counselling behaviour guidelines. Pharm Educ. 2021;5(2):87–96.
  • Schatz R, Belloto RJ, White DB, Bachmann K. Provision of drug information to patients by pharmacists: the impact of the Omnibus Budget Reconciliation Act of 1990 a Decade Later. Am J Ther. 2003;10(2):93–103.
  • Barnes JM, Riedlinger JE, McCloskey WW, Montagne M. Barriers to compliance with OBRA ’90 regulations in community pharmacies. Ann Pharmacother. 1996;30:1101–1105.
  • Sleath B. Pharmacist-patient relationships: authoritarian, participatory or default?Patient Educ Couns. 1996;28:253–263.
  • Erickson SR, Kirking DM, Sandusky M. Michigan Medicaid recipients’ perceptions of medication counseling as required by OBRA’90. J Am Pharm Assoc. 1998;38:333–338.
  • Vainio KK, Airaksinen MSA, Hyykky TT, Enlund KH. Effect of therapeutic class on counseling in community pharmacies. Ann Pharmacother. 2002;36:781–786.
  • Basheti IA, Reddel HK, Armour C, Bosnic-Anticevich SZ. Counselling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care. 2005;50:617–623.
  • Krass I. A comparison of clients’ experiences of counselling for prescriptions and over-the-counter medications in two types of pharmacies: validation of a research instrument. J Soc Admin Pharm. 1996;13:206–214.
  • Hassell K, Noyce PR, Rogers A, Harris J, Wilkinson J. Advice provided in British community pharmacies: what people want and what they get. J Health Serv Res Policy. 1998;3:219–225.
  • Morris LA, Tabak ER, Gondek K. Counseling patients about prescribed medication: 12-year trends. Med Care. 1997;35:996–1007.
  • Ibadan. In: Wikipedia. 2021. https://en.wikipedia.org/w/index.php?title=Ibadan&oldid=1024953884. Accessed 27 May 2022.
  • Alaqeel S, Abanmy NO. Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study. BMC Health Serv Res. 2015;15(1):557.
  • Osemene KP, Ihekoronye RM, Jegede A. Assessing counseling practices of community pharmacists in Nigeria. East Cent Afr J Pharm Sci. 2020;23(3):87–99.
  • Effectiveness of a Pharmacist-Acquired Medication History. Medscape. http://www.medscape.com/viewarticle/446575. Accessed 14 June 2022.
  • Dickinson D, Raynor DK. Ask the patients they may want to know more than you think. BMJ. 2003;327:861.
  • Nair K, Dolovich L, Cassels A, McCormack J, Levine M, et al. What patients want to know about their medications: focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–110.
  • Zieger DK, Mosier M, Buenaver BS, Okuyemi K. How much information about adverse effects of medication do patients want from physicians. Arch Intern Med. 2001;161:706–713.
  • Schommer JC, Wiederholt JB. Pharmacists’ perceptions of patients’ needs for counseling. Am J Health Syst Pharm. 1994;51(4):478–485.
  • Blom L, Jonkers R, Kok G, Bakker A. Patient education in 20 Dutch community pharmacies: analysis of audiotaped patient contacts. Int J Pharm Pract. 1998;6:72–76.
  • Myers ED, Calvert EJ. Information, compliance and side effect: a study of patients on antidepressant medication. Br J Clin Pharm. 1984;17:21–25.
  • Vatovec C, Kolodinsky J, Callas P, Hart C, Gallagher K. Pharmaceutical pollution sources and solutions: survey of human and veterinary medication purchasing, use, and disposal. J Environ Manage. 2021;285:112106.
  • Tong AYC, Peake BM, Braund R. Disposal practices for unused medications around the world. Environ Int. 2011;37(1):292–298.
  • Krueger JL, Hermansen-Kobulnicky CJ. Patient perspective of medication information desired and barriers to asking pharmacists questions. J Am Pharm Assoc. 2011;51(4):510–519.
  • Arnet I, Holden M, Antoniou S. Evaluation of a prompt card for community pharmacists performing consultations with patients on anticoagulation–lessons learned. Pharm Pract Granada. 2018;16(3):1244.
  • Cannon-Breland ML, Westrick SC, Kavookjian J, Berger BA, Shannon DM, Lorenz RA. Pharmacist self-reported antidepressant medication counseling. J Am Pharm Assoc. 2013;53(4):390–399.
  • Elaro A, Shah S, Armour CL, Bosnic-Anticevich S, et al. A snapshot of pharmacist attitudes and behaviors surrounding the management of pediatric asthma. J Asthma. 2015;52(9):957–968.
  • Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7(3):235–245.
  • Weiss MC, Platt J, Riley R. Medication decision making and patient outcomes in GP, nurse and pharmacist prescriber consultations. Prim Health Care Res Dev. 2015;16(5):513–527.
  • Olsson E, Ingman P, Ahmed B, Kalvemark SS. Pharmacist-patient communication in Swedish community pharmacies. Res Soc Adm Pharm. 2014;10(1):149–155.
  • Morrow N, Hargie O, Woodman C. Consumer perceptions of and attitudes to the advice-giving role of community pharmacists. Pharm J. 1993;251:25–27.
  • Greenhill N, Anderson C, Avery A, Pilnick A. Analysis of pharmacist–patient communication using the Calgary-Cambridge guide. Patient Educ Couns. 2011;83(3):423–431.
  • Boeni F, Arnet I, Hersberger KE. Adherence counseling during patient contacts in Swiss community pharmacies. Patient Prefer Adherence. 2015;9:597–605.
  • Barner JC, Bennett RW. Pharmaceutical care certificate program: assessment of pharmacists’ implementation into practice. J Am Pharm Assoc 1996. 1999;39(3):362–367.
  • Maes KA, Ruppanner JA, Imfeld-Isenegger TL, Hersberger KE, Lampert ML, Boeni F. Dispensing of prescribed medicines in swiss community pharmacies-observed counselling activities. Pharmacy. 2019;7(1):1.
  • Aslanpour Z, Smith FJ. Oral counselling on dispensed medication: a survey of its extent and associated factors in a random sample of community pharmacies. Int J Pharm Pract. 1997;5:57–63.
  • Puumalainen I, Kansanaho H, Varunki M, Ahonen R, Airaksinen M. Usefulness of the USP medication counselling behavior guidelines. Pharm World Sci. 2005;27(6):465–468.
  • Kimberlin CL, Jamison AN, Linden S, Winterstein AG. Patient counseling practices in US pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling. J Am Pharm Assoc. 2011;51(4):527–534.
  • Odukoya OK, Chui MA, Pu J. Factors influencing quality of patient interaction at community pharmacy drive-through and walk-in counselling areas. Int J Pharm Pract. 2014;22(4):246–256.
  • Cocohoba J, Comfort M, Kianfar H, Johnson MO. A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies. J Manag Care Pharm. 2013;19(6):454–460.
  • Schommer JC, Gaither CA. A segmentation analysis for pharmacists’ and patients’ views of pharmacists’ roles. Res Soc Adm Pharm. 2014;10(3):508–528.
  • Osman NM, Bond CM, Mackenzie J, Williams S. Asthma advice giving by community pharmacy. Int J Pharm Pract. 1999;7:12–17.
  • Pugh CB. Pre-OBRA ’90 medicaid survey: how community pharmacy practice is changing. Am Pharm. 1995;S35:17–23.
  • Pronk M, Blom L, Jonkers R, Rogers EM, Bakker A, Blaey KJ. Patient oriented activities in Dutch community pharmacy: diffusion of innovations. Pharm World Sci. 2002;24:154–161.
  • Sepucha K, Ozanne EM. How to define and measure concordance between patients’ preferences and medical treatments: a systematic review of approaches and recommendations for standardization. Patient Educ Couns. 2010;78(1):12–23.
  • Epstein RM, Franks P, Fiscella K, Shields CG, Meldrum SC, Kravitz RL, et al. Measuring patient-centered communication in patient-physician consultations: theoretical and practical issues. Soc Sci Med. 2005;61(7):1516–1528.